Researchers have spent years chasing a cure for Alzheimer’s, focusing on how proteins called amyloid clump together in the brain. Back in the 1990s, scientists, including one leading expert, realized that these clumps might harm brain cells and trigger inflammation. At first, they thought fixing thi
For decades, drug testing followed the same slow rhythm. Researchers ran trials in stages, then paused for months to analyze data before asking regulators for the next step. Patients waited years for treatments while paperwork piled up. Now, a new FDA approach cuts out the waiting by letting regulat
Back in 2009, a small group of experts started giving free, no-nonsense feedback to anyone trying to turn a muscle-disease idea into a real treatment. Their main job was to stop bad drugs from reaching patients too early, and to make sure good drugs had a fair shot at proving they worked. Over 15 ye
Asthma is a tricky condition. For a long time, scientists thought they knew what caused the inflammation in the lungs. They blamed leukotrienes, chemicals made by white blood cells. But now, a new discovery might change everything. Researchers found something unexpected. There are other molecules,
Cancer is often seen as a relentless foe. But what if some cancers are not so aggressive? What if they can be controlled by the body's own defenses? This idea is not just a theory. It is being explored in a new way. Scientists have noticed that some cancers do not grow or spread. They stay in the b
Scientists have created new molecules to fight colorectal cancer. These molecules target a specific pathway in cells that is often overactive in cancer. The most promising molecule, called L20, stops cancer cells from growing and spreading. L20 works by sticking to a protein called STAT3. This prot
Gallbladder cancer is a serious disease. It is the most common cancer of the bile ducts. Finding new treatments is very important. Researchers have found something promising. It is called total glucosides of paeony, or TGP. This comes from a traditional Chinese herb called Bai Shao. TGP does two im
SHP2, a protein known for its role in various diseases like cancer and RASopathies, is a hot topic in medical research. It's often mutated in these conditions, making it a prime target for new drug development. SHP2 is part of a complex system that helps cells grow and communicate, and it's tightly
Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi
In the world of medical research, a new player has emerged that could change the game for people with a tough type of blood cancer called acute myeloid leukemia (AML). This cancer is notorious for being resistant to many treatments, especially in cases with complex genetic issues like MECOM rearrang
